John Robinson

2.0k total citations
45 papers, 1.3k citations indexed

About

John Robinson is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, John Robinson has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 15 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in John Robinson's work include Catalytic C–H Functionalization Methods (6 papers), Cancer Mechanisms and Therapy (6 papers) and HIV/AIDS drug development and treatment (5 papers). John Robinson is often cited by papers focused on Catalytic C–H Functionalization Methods (6 papers), Cancer Mechanisms and Therapy (6 papers) and HIV/AIDS drug development and treatment (5 papers). John Robinson collaborates with scholars based in United States, United Kingdom and Germany. John Robinson's co-authors include P. Andrew Evans, Jade D. Nelson, Klara Abravaya, Ning Tang, Erich W. Baum, Aleem Fazal, Shihai Huang, George J. Schneider, Jun Qin and Phil Evans and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

John Robinson

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Robinson United States 21 614 366 249 194 177 45 1.3k
James M. Bennett United Kingdom 24 460 0.7× 1.2k 3.3× 135 0.5× 32 0.2× 189 1.1× 48 2.0k
Hiroyuki Hayakawa Japan 27 923 1.5× 1.1k 2.9× 839 3.4× 69 0.4× 819 4.6× 91 3.1k
Vincent Hernandez China 12 698 1.1× 761 2.1× 260 1.0× 75 0.4× 163 0.9× 13 1.6k
Douglas G. Mack United States 28 132 0.2× 438 1.2× 1.2k 4.7× 29 0.1× 174 1.0× 64 2.5k
Charles Shipman United States 19 301 0.5× 446 1.2× 678 2.7× 67 0.3× 376 2.1× 47 1.7k
Peter W. White Canada 21 219 0.4× 417 1.1× 576 2.3× 52 0.3× 287 1.6× 46 1.3k
Jacob J. Clement United States 22 358 0.6× 573 1.6× 260 1.0× 17 0.1× 236 1.3× 56 1.4k
Vincent Lévêque United States 28 219 0.4× 549 1.5× 643 2.6× 149 0.8× 659 3.7× 41 1.7k
Michel Liuzzi Canada 22 275 0.4× 726 2.0× 542 2.2× 72 0.4× 270 1.5× 48 1.6k
Shizuko Sei United States 26 284 0.5× 512 1.4× 306 1.2× 21 0.1× 629 3.6× 73 1.9k

Countries citing papers authored by John Robinson

Since Specialization
Citations

This map shows the geographic impact of John Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Robinson more than expected).

Fields of papers citing papers by John Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Robinson. The network helps show where John Robinson may publish in the future.

Co-authorship network of co-authors of John Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of John Robinson. A scholar is included among the top collaborators of John Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Robinson. John Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, John, Luchuo Engelbert Bain, Angus J. Morrison, et al.. (2025). Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments. Journal of Medicinal Chemistry. 68(6). 6815–6831. 1 indexed citations
2.
Ali, Amjad, Scott B. Hoyt, Yusheng Xiong, et al.. (2016). Imidazopyridyl compounds as aldosterone synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(2). 143–146. 8 indexed citations
3.
Shin, Yoo Seob, Katsuyuki Takeda, Yoshiki Shiraishi, et al.. (2011). Inhibition of Pim1 Kinase Activation Attenuates Allergen-Induced Airway Hyperresponsiveness and Inflammation. American Journal of Respiratory Cell and Molecular Biology. 46(4). 488–497. 34 indexed citations
4.
Robinson, John, et al.. (2011). The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease. Cellular Immunology. 272(2). 200–213. 38 indexed citations
5.
Fathi, Amir T., Omotayo Arowojolu, Takashi Sato, et al.. (2011). A potential therapeutic target for FLT3-ITD AML: PIM1 kinase. Leukemia Research. 36(2). 224–231. 47 indexed citations
6.
Baugh, Mark, David Jonathan Bennett, Jiaqiang Cai, et al.. (2010). 1H-Imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: Separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka. Bioorganic & Medicinal Chemistry Letters. 21(3). 932–935. 6 indexed citations
7.
Cai, Jiaqiang, Xavier Fradera, David Jonathan Bennett, et al.. (2010). 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorganic & Medicinal Chemistry Letters. 20(15). 4507–4510. 16 indexed citations
8.
Wright, Dale, Stefan Groß, John Robinson, et al.. (2009). Inhibition of T cell function in vitro and in vivo using small molecule antagonists of PIM kinases (35.33). The Journal of Immunology. 182(Supplement_1). 35.33–35.33. 1 indexed citations
9.
Hendricks, R., Jay B. Fell, James F. Blake, et al.. (2009). Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(13). 3637–3641. 27 indexed citations
10.
11.
Huang, Shihai, Ning Tang, Brian Erickson, et al.. (2009). Principles and analytical performance of Abbott RealTime High Risk HPV test. Journal of Clinical Virology. 45. S13–S17. 52 indexed citations
12.
Woessner, Richard, Shelley Allen, Qian Zhao, et al.. (2007). ARRY-520, a KSP inhibitor with efficacy and pharmacodynamic activity in animal models of solid tumors. Cancer Research. 67. 1433–1433. 9 indexed citations
13.
Evans, Phil, et al.. (2007). Enantioselective Total Synthesis of the Polycyclic Guanidine‐Containing Marine Alkaloid (−)‐Batzelladine D. Angewandte Chemie International Edition. 46(39). 7417–7419. 52 indexed citations
14.
Huang, Shihai, Ning Tang, Ka‐Cheung Luk, et al.. (2007). Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Research. 35(16). e101–e101. 43 indexed citations
15.
Tang, Ning, Shihai Huang, Gavin Cloherty, et al.. (2007). A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A–H, group O and group N samples. Journal of Virological Methods. 146(1-2). 236–245. 73 indexed citations
16.
Evans, P. Andrew, Erich W. Baum, Aleem Fazal, et al.. (2006). New metal-catalyzed carbocyclization reactions for the construction of complex natural products. ARKIVOC. 2006(7). 338–358. 8 indexed citations
17.
Piscopio, Anthony D. & John Robinson. (2004). Recent applications of olefin metathesis to combinatorial chemistry. Current Opinion in Chemical Biology. 8(3). 245–254. 16 indexed citations
18.
Leckie, Gregor, George J. Schneider, Klara Abravaya, et al.. (2003). Performance attributes of the LCx® HCV RNA quantitative assay. Journal of Virological Methods. 115(2). 207–215. 15 indexed citations
19.
Abravaya, Klara, Gregor Leckie, R. H. Perry, et al.. (2001). A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. Journal of Virological Methods. 95(1-2). 81–92. 35 indexed citations
20.
Poynter, D., et al.. (1960). Recent experiences with vaccination.. Veterinary Record. 72(48). 1078–1086. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Bennett Breakdown of academic impact, for papers by Hiroyuki Hayakawa Breakdown of academic impact, for papers by Vincent Hernandez Breakdown of academic impact, for papers by Douglas G. Mack Breakdown of academic impact, for papers by Charles Shipman Breakdown of academic impact, for papers by Peter W. White Breakdown of academic impact, for papers by Jacob J. Clement Breakdown of academic impact, for papers by Vincent Lévêque Breakdown of academic impact, for papers by Michel Liuzzi Breakdown of academic impact, for papers by Shizuko Sei
Rankless by CCL
2026